Highlights:
- NeuroNews exclusively interviews Sheila Martins (Porto Alegre, Brazil) who provides an update on the RESILIENT team’s plan of action following the trial’s positive results, and details how the trial is set to shape stroke systems of care in developing countries.
- The role of social media in medicine is inevitable expanding. Georgios Matis (Cologne, Germany) writes about the benefits of these platforms, but urges all to “proceed with caution”.
- Profile: Patrick Brouwer (Leiden, The Netherlands)
- Neuromodulation: The clinical utility of evoked compound action potentials is echoed by data from Evoke and Avalon
